Livedo reticularis
Livedo reticularis chiratidzo cheganda chinosanganisira mottled reticulated vascular pattern inoratidzika semucheka une ruvara rwepepuru. Inogona kuwedzera kana ganda rikasangana nechando, uye inowanzoonekwa pazasi pegumbo. Kuchinja kwemavara kunokonzerwa nekuderera kwekuyerera kweropa kuburikidza nearterioles dzinopa cutaneous capillaries, zvichikonzera kuti ropa riite deoxygenated, richiratidza ruvara rweblue. Izvi zvinogona kukonzerwa nehyperlipidemia, microvascular hematological disorders kana anemia, pamwe nekushomeka kwekudya, zvirwere zveautoimmune, uye mishonga / chepfu.
☆ AI Dermatology — Free Service
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Lesioni inokonzerwa nekuoma kweinfrarenal aortoiliac stenosis.
relevance score : -100.0%
ReferencesLivedo reticularis (LR) chimiro cheganda chinoratidzwa nechinguva chidiki kana kuti chinogara, chine mavara matsvuku‑bhuruu kusvika kupuruu, uye chine net‑like pattern. Zvinonyanya kubata vakadzi vezera repakati uye kazhinji hazvina zviratidzo (asymptomatic). Kune rimwe divi, livedo racemosa (LRC) chirwere chakakomba chinowanzobatanidzwa ne‑antiphospholipid antibody syndrome.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
Livedo reticularis (LR) is a cutaneous physical sign characterized by transient or persistent, blotchy, reddish-blue to purple, net-like cyanotic pattern. LR is a benign disorder affecting mainly middle-aged females, whereas livedo racemosa (LRC) is pathologic, commonly associated with antiphospholipid antibody syndrome.
